Santa Monica:Antibiotics in Sepsis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== Unknown Source == | == Unknown Source == | ||
*Primary Therapy | |||
** piperacillin/tazobactam 4.5g IV q6h OR cefepime 1g IV q8h OR meropenem 1g IV q8h | |||
**+/- [[vancomycin]] 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | |||
**+/- gentamicin 7mg/kg/dose IV q24h | |||
**+/- fluconazole 400mg IV q24h | |||
*If allergy or prior exposure | |||
** [[aztreonam]] 2g IV q8h OR levofloxacin 750mg IV q24h | |||
**+/- [[vancomycin]] 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | |||
**+/- gentamicin 7mg/kg/dose IV q24h | |||
**+/- fluconazole 400mg IV q24h | |||
==Pneumonia (Community)== | ==Pneumonia (Community)== | ||
* Comm. Acquired | |||
**[[Ceftriaxone]] 1g IV q24h | |||
**AND, Azithromycin 500mg IV q24h | |||
*If allergy or prior exposure | |||
**Levofloxacin 750mg IV q24h AND [[Aztreonam]] 2g IV q8h | |||
==Pneumonia (Healthcare Assoc/Pseudomonas Risk)== | ==Pneumonia (Healthcare Assoc/Pseudomonas Risk)== | ||
* Primary therapy | |||
** cefepime 1g IV q8h OR piperacillin/tazobactam 4.5g IV q6h | |||
**+/- azithromycin 500mg IV q24h | |||
**+/- [[vancomycin]] 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | |||
*If allergy or prior exposure | |||
** levofloxacin 750mg IV q24h | |||
**+/- azithromycin 500mg IV q24h | |||
**+/- gentamicin extended interval 7mg/kg/dose IV q24h | |||
==Abdominal/Pelvic== | ==Abdominal/Pelvic== | ||
*Primary therapy | |||
** piperacillin/tazobactam 4.5g IV q6h OR ertapenem 1g IV q24h OR ceftriaxone 1g IV q24h | |||
**AND, metronidazole 500mg IV q8h | |||
** [[vancomycin]] 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | |||
*If allergy or prior exposure | |||
**[[aztreonam]] 2g IV q8h | |||
**AND, metronidazole 500mg IV q8h | |||
**+/- [[vancomycin]] 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | |||
==Urosepsis== | ==Urosepsis== | ||
*Primary therapy | |||
**ertapenem 1g IV q24h OR ceftriaxone 1g IV q24h | |||
*If allergy or prior exposure | |||
**ciprofloxacin 400mg IV q12h OR ciprofloxacin 400mg IV q12h | |||
**AND, gentamicin 7mg/kg/dose IV q24h | |||
==Heme/Onch== | ==Heme/Onch== | ||
*Primary therapy | |||
**meropenem 1g IV q8h | |||
**+/- [[vancomycin]] 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | |||
*If allergy or prior exposure | |||
**[[aztreonam]] 2g IV q8h | |||
**+/- [[vancomycin]] 15mg/kg/dose IV q12h [Maximum dose of 1500mg] | |||
==See Also== | ==See Also== | ||
Revision as of 18:40, 14 May 2015
Unknown Source
- Primary Therapy
- piperacillin/tazobactam 4.5g IV q6h OR cefepime 1g IV q8h OR meropenem 1g IV q8h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- +/- gentamicin 7mg/kg/dose IV q24h
- +/- fluconazole 400mg IV q24h
- If allergy or prior exposure
- aztreonam 2g IV q8h OR levofloxacin 750mg IV q24h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- +/- gentamicin 7mg/kg/dose IV q24h
- +/- fluconazole 400mg IV q24h
Pneumonia (Community)
- Comm. Acquired
- Ceftriaxone 1g IV q24h
- AND, Azithromycin 500mg IV q24h
- If allergy or prior exposure
- Levofloxacin 750mg IV q24h AND Aztreonam 2g IV q8h
Pneumonia (Healthcare Assoc/Pseudomonas Risk)
- Primary therapy
- cefepime 1g IV q8h OR piperacillin/tazobactam 4.5g IV q6h
- +/- azithromycin 500mg IV q24h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- If allergy or prior exposure
- levofloxacin 750mg IV q24h
- +/- azithromycin 500mg IV q24h
- +/- gentamicin extended interval 7mg/kg/dose IV q24h
Abdominal/Pelvic
- Primary therapy
- piperacillin/tazobactam 4.5g IV q6h OR ertapenem 1g IV q24h OR ceftriaxone 1g IV q24h
- AND, metronidazole 500mg IV q8h
- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- If allergy or prior exposure
- aztreonam 2g IV q8h
- AND, metronidazole 500mg IV q8h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
Urosepsis
- Primary therapy
- ertapenem 1g IV q24h OR ceftriaxone 1g IV q24h
- If allergy or prior exposure
- ciprofloxacin 400mg IV q12h OR ciprofloxacin 400mg IV q12h
- AND, gentamicin 7mg/kg/dose IV q24h
Heme/Onch
- Primary therapy
- meropenem 1g IV q8h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
- If allergy or prior exposure
- aztreonam 2g IV q8h
- +/- vancomycin 15mg/kg/dose IV q12h [Maximum dose of 1500mg]
See Also
Source
Santa-Monica UCLA 5/12
